碳点纳米粒子为基础的治疗方法在主要的神经疾病
Mohd Haseeb1, Mustafa Aziz Hatiboglu1,2
1Department of Molecular Biology, Beykoz Institute of Life Sciences and Biotechnology, Bezmialem Vakif University, Yalıköy St., Beykoz, Istanbul, 34820, Turkey.
Mini reviews in medicinal chemistry
|October 15, 2025
概括
碳点通过改善通过血脑屏障 (BBB) 传递药物来治疗神经系统疾病 (NDs) 是有前途的. 需要进一步的研究,特别是对于多发性硬化症和脑瘤等疾病.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 神经科学是一个神经科学.
背景情况:
- 神经系统疾病 (NDs) 带来了重要的医疗保健挑战,有效治疗方法有限.
- 目前的疗法往往无法穿越血脑屏障 (BBB) 进行向药物输送.
- 基于纳米粒子的策略,特别是碳点 (CD),由于其独特的特性,提供了潜在的解决方案.
研究的目的:
- 审查碳点 (CDs) 对主要神经疾病 (NDs) 的治疗潜力.
- 巩固关于CD合成,特性和在ND治疗中的应用的研究.
- 为了确定基于CD的治疗NDs的研究差距.
主要方法:
- 对过去15年的研究进行了全面的文献综述.
- 分析碳点合成,表征和功能化用于药物输送.
- 对碳点在治疗阿尔茨海默病,帕金森病,多发性硬化症和脑瘤方面的现有研究进行评估.
主要成果:
- 碳点 (CD) 具有生物相容性,光和易于用于药物输送的功能.
- 磁盘显示了增强血脑屏障 (BBB) 透和在神经疾病中向药物输送的潜力.
- 在多发性硬化症 (MS) 和脑瘤中,基于CD的治疗方法存在有限的原始研究.
结论:
- 碳点是开发神经系统疾病新型治疗和药物输送策略的有希望的平台.
- 进一步的研究对于充分探索CD的治疗应用至关重要,特别是在MS和脑瘤等研究不足的领域.
- CD提供了一种生物相容且有效的方法来克服ND治疗当前的局限性.
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
960
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
960
01:15Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
01:22Alzheimer's Disease: Treatment
822
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
822